IRIS Accounts Production v24.2.0.383 07907357 Board of Directors 1.2.23 31.1.24 31.1.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh079073572023-01-31079073572024-01-31079073572023-02-012024-01-31079073572022-01-31079073572022-02-012023-01-31079073572023-01-3107907357ns15:EnglandWales2023-02-012024-01-3107907357ns14:PoundSterling2023-02-012024-01-3107907357ns10:Director12023-02-012024-01-3107907357ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3107907357ns10:SmallEntities2023-02-012024-01-3107907357ns10:AuditExemptWithAccountantsReport2023-02-012024-01-3107907357ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3107907357ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3107907357ns10:FullAccounts2023-02-012024-01-310790735712023-02-012024-01-3107907357ns10:Director22023-02-012024-01-3107907357ns10:Director32023-02-012024-01-3107907357ns10:Director42023-02-012024-01-3107907357ns10:RegisteredOffice2023-02-012024-01-3107907357ns5:CurrentFinancialInstruments2024-01-3107907357ns5:CurrentFinancialInstruments2023-01-3107907357ns5:ShareCapital2024-01-3107907357ns5:ShareCapital2023-01-3107907357ns5:RetainedEarningsAccumulatedLosses2024-01-3107907357ns5:RetainedEarningsAccumulatedLosses2023-01-3107907357ns5:PlantMachinery2023-02-012024-01-3107907357ns5:NetGoodwill2023-01-3107907357ns5:NetGoodwill2023-02-012024-01-3107907357ns5:NetGoodwill2024-01-3107907357ns5:NetGoodwill2023-01-3107907357ns5:PlantMachinery2023-01-3107907357ns5:PlantMachinery2024-01-3107907357ns5:PlantMachinery2023-01-3107907357ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-01-3107907357ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-01-31
REGISTERED NUMBER: 07907357 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JANUARY 2024

FOR

ADVANCE HISTOPATHOLOGY LABORATORY LTD

ADVANCE HISTOPATHOLOGY LABORATORY LTD (REGISTERED NUMBER: 07907357)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Chartered Certified Accountants' Report 5

ADVANCE HISTOPATHOLOGY LABORATORY LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2024







DIRECTORS: Ms M R Nohadani
Ms T J Stamp
Prof G W H Stamp
G F W Stamp





REGISTERED OFFICE: 14-15 Harelands Courtyard Offices
Moor Road
Melsonby
Richmond
North Yorkshire
DL10 5NY





REGISTERED NUMBER: 07907357 (England and Wales)





ACCOUNTANTS: Momentum Taxation and Accountancy Ltd
Harelands Courtyard Offices
Moor Road
Melsonby
Richmond
North Yorkshire
DL10 5NY

ADVANCE HISTOPATHOLOGY LABORATORY LTD (REGISTERED NUMBER: 07907357)

BALANCE SHEET
31 JANUARY 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - 375,000
Tangible assets 5 86,885 86,798
86,885 461,798

CURRENT ASSETS
Debtors 6 939,324 16,332
Cash at bank 670,991 788,100
1,610,315 804,432
CREDITORS
Amounts falling due within one year 7 614,834 277,897
NET CURRENT ASSETS 995,481 526,535
TOTAL ASSETS LESS CURRENT LIABILITIES 1,082,366 988,333

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 1,082,266 988,233
1,082,366 988,333

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 October 2024 and were signed on its behalf by:





Prof G W H Stamp - Director


ADVANCE HISTOPATHOLOGY LABORATORY LTD (REGISTERED NUMBER: 07907357)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2024


1. STATUTORY INFORMATION

Advance Histopathology Laboratory Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost, 20% on cost and 10% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 11 (2023 - 12 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 February 2023 375,000
Disposals (375,000 )
At 31 January 2024 -
NET BOOK VALUE
At 31 January 2024 -
At 31 January 2023 375,000

ADVANCE HISTOPATHOLOGY LABORATORY LTD (REGISTERED NUMBER: 07907357)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2024


5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 February 2023 659,393
Additions 24,722
At 31 January 2024 684,115
DEPRECIATION
At 1 February 2023 572,595
Charge for year 24,635
At 31 January 2024 597,230
NET BOOK VALUE
At 31 January 2024 86,885
At 31 January 2023 86,798

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 920,880 -
Other debtors 18,444 16,332
939,324 16,332

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 46,667 66,667
Taxation and social security 164,589 43,579
Other creditors 403,578 167,651
614,834 277,897

CHARTERED CERTIFIED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS
ON THE UNAUDITED FINANCIAL STATEMENTS OF
ADVANCE HISTOPATHOLOGY LABORATORY LTD


The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Advance Histopathology Laboratory Ltd for the year ended 31 January 2024 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/rulebook.

This report is made solely to the Board of Directors of Advance Histopathology Laboratory Ltd, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Advance Histopathology Laboratory Ltd and state those matters that we have agreed to state to the Board of Directors of Advance Histopathology Laboratory Ltd, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Advance Histopathology Laboratory Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Advance Histopathology Laboratory Ltd. You consider that Advance Histopathology Laboratory Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Advance Histopathology Laboratory Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Momentum Taxation and Accountancy Ltd
Harelands Courtyard Offices
Moor Road
Melsonby
Richmond
North Yorkshire
DL10 5NY


Date: .............................................